Results 291 to 300 of about 29,459,690 (400)

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

A Sequel to a Public Health Ruling Concerning Streptococcic Mastitis

, 1936
Charles S Bryan, Gail Turney
openalex   +2 more sources

Rehabilitation needs at rural primary health care settings: perspectives of health center nurses in Burera district of Rwanda. [PDF]

BMC Prim Care
Dukuzimana MJ, Ukwizabigira JB, Muhire C, Jokinen K, Tumusiime DK, Murtonen KP, Ngwakongnwi E.   +6 more
europepmc   +1 more source

Endoglin mediates the tumor‐ and metastasis‐promoting traits of stromal myofibroblasts in human breast carcinomas

Molecular Oncology, EarlyView.
Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo, Yoshihiro Mezawa, Zixu Wang, Ahmet Acar, Yasuhiko Ito, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Yataro Daigo, Takuya Shirakihara, Akira Orimo   +11 more
wiley   +1 more source

Lasting Impact of Patient-Led Medical Education. [PDF]

Clin Teach
Sawatzky B, Kline C.
europepmc   +1 more source

No time for complacency on the road to gender equality

The Lancet Global Health, 2020
The Lancet Global Health
doaj  

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Addressing Inequalities in Long Covid Healthcare: A Mixed-Methods Study on Building Inclusive Services. [PDF]

Health Expect
Mir G, Mullard J, Parkin A, Lee C, Clarke J, De Kock JH, Prociuk D, Darbyshire JL, Evans S, Sivan M, LOCOMOTION Consortium.   +10 more
europepmc   +1 more source

Kakovost življenja lahko izmerimo

Obzornik zdravstvene nege, 1990
World Health Forum
doaj  

Giving the climate policy ratchet a healthy turn

The Lancet Planetary Health, 2021
The Lancet Planetary Health
doaj